LAV Biosciences Fund V, L.P. — SEC insider filings
SEC reporting owner CIK 1764435. 4 insider filings on record with FilingPulse; latest filed 2026-09-29.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2021-02-09 to 2026-09-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 1,500,000 shares, $8,250,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 1,000,000 shares @ $5.50 ($5,500,000) in Terns Pharmaceuticals, Inc., filed 2022-11-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) | 10% owner | 2 | — | 3 legs · 1,500,000 sh · $8,250,000 | 9 |
| ADARx Pharmaceuticals, Inc. (ADRX) | 10% owner | 2 | — | — | 12 |
Insider filings — LAV Biosciences Fund V, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-29 | 4 | ADARx Pharmaceuticals, Inc. (ADRX) jointly with LAV Fund VI Opportunities, L.P., LAV Fund VI, L.P. | Conversion (C): 8,908,775 · Conversion (C): 1,667,469 · Conversion (C): 513,067 · Conversion (C): 153,868 · Conversion (C): 307,738 · Conversion (C): 307,738 · +6 more | EDGAR |
| 2026-09-24 | 3 | ADARx Pharmaceuticals, Inc. (ADRX) jointly with LAV Fund VI Opportunities, L.P., LAV Fund VI, L.P. | Holdings only — no transactions reported | EDGAR |
| 2022-11-28 | 4 | Terns Pharmaceuticals, Inc. (TERN) jointly with Hopewell Resources Holdings Ltd, LAV Aqua Ltd, Oriental Spring Venture Ltd | Sale (S): 1,000,000 @ $5.50 · Sale (S): 333,334 @ $5.50 · Sale (S): 166,666 @ $5.50 | EDGAR |
| 2021-02-09 | 4 | Terns Pharmaceuticals, Inc. (TERN) jointly with Hopewell Resources Holdings Ltd, Oriental Spring Venture Ltd, LAV Aqua Ltd | Conversion (C): 1,392,857 · Conversion (C): 696,428 · Conversion (C): 1,286,698 · Conversion (C): 1,405,583 · Conversion (C): 1,392,857 (derivative) · Conversion (C): 696,428 (derivative) · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1764435 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs